Mitchell E. Levinson - 22 Mar 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Reporting relationship: Chief Strategy Officer
Issuer ticker: PLSE
Reported as of: 22 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Mar 2023, 16:30:32 UTC
Prior SEC filing: 20 Aug 2021
Next SEC filing: 10 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact

Key filing fact

Mitchell E. Levinson filed Form 4 for Pulse Biosciences, Inc. (PLSE) on 24 Mar 2023.

Key facts

This page summarizes Mitchell E. Levinson's Form 4 filing for Pulse Biosciences, Inc. (PLSE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Mar 2023, 16:30.

Change

Previous filing in this sequence was filed on 20 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +35,000
Change %
Price
Shares after: 35,000
Date: 22 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $2.92
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option was granted on March 22, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to performance-based vesting criteria. 8,750 shares will vest in equal annual installments over the following four years on or about December 31, starting in 2023, subject to achievement of the vesting criteria and the reporting person's continued service through each vesting date.

Footnote F2

Not Applicable